Assignee
BYOMASS INC
US·0 granted patents·3 pending applications·0 citations·filing 2022–2023
Top patents by PatentIndex Score
3 records- 0161US2025382359A1Targeting gdf15-gfral pathwayBYOMASS INC·Filed 2022·Application pending·0 cites
- 0261US2025109190A1Myeloproliferative conditionsBYOMASS INC·Filed 2023·Application pending·0 cites
- 0361US2025019427A1Anti-gdf15 antibodies, compositions and uses thereofBYOMASS INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →